Mark Gouldson

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Mark Gouldson is an author at Merck Canada Inc. (Canada) specializing in endometrial cancer, microsatellite instability in endometrial cancer, and microsatellite instability subtypes.

ORCID

Publications per year

2021–2024

Publications

Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer

Elizabeth Thurgar, Mark Gouldson, Suzette M. Matthijsse et al. · Journal of Medical Economics · 2021 · 36 citations · Full text

Medicine, Oncology, Pharmacoeconomics +16

Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan

Shigeki Nakamura, Masashi Mikami, Tomoyuki Hayamizu et al. · Expert Review of Vaccines · 2024 · 13 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacoeconomics +17

1–2 of 2